Johnson & Johnson beats Q2 estimates with EPS $2.90 and revenue $25.3B, ups guidance

 

Johnson & Johnson beats Q2 estimates with EPS $2.90 and revenue $25.3B, raises 2026 adjusted EPS guidance to $11.60–$11.75

• Fiscal Q2 2026 non-GAAP EPS of $2.90 rose 5% year over year.
• Q2 company revenue of $25.3B grew 7% year over year.
• Updated 2026 sales outlook to $100.8–$101.4B alongside higher adjusted EPS guidance.

https://finviz.com/stock?t=JNJ&p=d